Search for: "Hospira"
Results 101 - 120
of 487
Sort by Relevance
|
Sort by Date
3 Dec 2016, 7:52 am
Hospira, Inc., Civil Action No. 15-839-RGA (D.Del., November 30, 2016), the Court issued its claim constructions for the two phrases in dispute in claims 1 and 8 of U.S. [read post]
9 Nov 2016, 4:00 am
In Hospira, the lower court judge had characterized the deference as ‘elbow room’. [read post]
6 Oct 2016, 2:03 pm
Never too late 114 [week ending on Sunday 18 September] | Commissioner unveils new copyright package | Open letter from Wikimedia et al on copyright package| Globalisation, Globalisation, Globalisation| Philip Morris loses investment arbitration | EPIP highlights | 20 million thanks | Tea & trade secret theft | Patent quality conference | free wifi networks & copyright infringement | Chiefs in Intellectual Property summit | Innovation and its discontents | GS… [read post]
5 Oct 2016, 6:59 pm
[1] The Dutch Court of Appeal – as the District Court in the merits case – considered that Novartis could claim priority and therefore did consider indirect infringement, other than the UK High Court (15 March 2013) and Court of Appeal (19 December 2013) in Hospira v Novartis. [read post]
27 Sep 2016, 9:10 am
A lively discussion of the English approach to obviousness as applied in the Hospira v Genotech patent revocation application. [read post]
22 Sep 2016, 7:10 am
One of the joys of blogging is that commenters, as well as alerting the hapless blogger to typographical errors and terminological infelicities, can alert to interesting aspects of a decision that did not seem striking at a first review.So it was with the case of the appeal decision Hospira v Genentech [2016] EWCA Civ 780, which, when this Kat first reviewed it, seemed to be a fairly straightforward case of the first instance judgment being affirmed on appeal – no, the judge did not… [read post]
20 Sep 2016, 4:29 am
These reports include some of the international challenges faced by IP, Katfriend David Lim's account of being a Congress first-timer, and a delicious recipe.PREVIOUSLY ON NEVER TOO LATENever too late 113 [week ending on Sunday 11 September] Clinical trial data | Parody and free use in Germany | Infringing donuts | CJEU decision in GS Media | Fujifilm Kyowa v AbbVie | UK and the UPC | General Data Protection… [read post]
17 Sep 2016, 4:56 am
PREVIOUSLY ON NEVER TOO LATENever too late 112 [week ending on Sunday 4 September] 3 Cubist antibiotic patents revoked| Milan Court rejects application for 'blank' blocking order | Leaked copyright draft directive| Thursday Titibits | Super Kat exclusive| Mexico's new opposition system | EU General Data Protection Regulation | Hospira v Cubist | My My Mylan | Kasting Kall for InternkatsNever too late… [read post]
5 Sep 2016, 1:10 pm
A closer look at Hospira v Cubist and daptomycin micellesIPKat returns to the Hospira v Cubist case to look in more detail at the claim relating to purifying daptomycin by altering by PH.* My My Mylan: The Trademark Silver Lining for Mylan's EPIPENMylan has recently come under fire for raising the price of the EPIPEN. [read post]
2 Sep 2016, 3:39 am
The IPKat posted a report earlier this week of the case Hospira v Cubist, in which three patents belonging to Cubist were revoked by Mr Justice Carr. [read post]
30 Aug 2016, 7:52 am
Hospira alleged that the patent was not entitled to either of its priority dates. [read post]
29 Aug 2016, 11:03 am
| Weekly roundup: Friday Fun Never too late 107 [week ending on Sunday 31 July] Article 28 declarations |Costs of ISP blocking injunctions |Friday Fantasies, featuring legal challenges to Brexit and more |Huawei v Samsung |Hospira v Genentech |Questions on Article 3(b) SPC referred to CJEU |Book Review: Trade Secret Protection |Pokémon Go [read post]
23 Aug 2016, 9:41 am
| Weekly roundup: Friday Fun Never too late 107 [week ending on Sunday 31 July] Article 28 declarations |Costs of ISP blocking injunctions |Friday Fantasies, featuring legal challenges to Brexit and more |Huawei v Samsung |Hospira v Genentech |Questions on Article 3(b) SPC referred to CJEU |Book Review: Trade Secret Protection |Pokémon GoNever too late 106 [week ending on Sunday 24 July] | Innovation… [read post]
19 Aug 2016, 2:04 am
| Weekly roundup: Friday Fun Never too late 107 [week ending on Sunday 31 July] Article 28 declarations |Costs of ISP blocking injunctions |Friday Fantasies, featuring legal challenges to Brexit and more |Huawei v Samsung |Hospira v Genentech |Questions on Article 3(b) SPC referred to CJEU |Book Review: Trade Secret Protection |Pokémon GoNever too late 106 [week ending on Sunday 24 July] | Innovation… [read post]
9 Aug 2016, 7:50 am
Hospira, Inc., 1-15-cv-00839 (DED August 5, 2016, Order) (Andrews, J.) [read post]
8 Aug 2016, 12:50 pm
.* Friday FunInternkat Ellie Wilson brings us a weekly roundup, including the new MIP European Patent Reform Forum, and University of New Hampshire's search for a new Dean.PREVIOUSLY ON NEVER TOO LATENever too late 107 [week ending on Sunday 31 July] Article 28 declarations |Costs of ISP blocking injunctions |Friday Fantasies, featuring legal challenges to Brexit and more |Huawei v Samsung |Hospira v Genentech |Questions on Article 3(b) SPC… [read post]
3 Aug 2016, 7:17 am
Hospira’s case on obviousness relied on prior art which disclosed trastuzumab was in phase II clinical trials for the treatment of breast cancer. [read post]
29 Jul 2016, 10:00 am
The Court of Appeal handed down its decision yesterday in Hospira v Genentech (with the first instance decision reported by this Kat here). [read post]
25 Jul 2016, 1:40 pm
* Quia timet, de minimis and Novartis v Hospira: Mr Justice Arnold speeds through Napp v Dr Reddy pain disputeKatfriend Amy Crouch brings us the two decisions and developments in the Napp v Dr Reddy's and Sandoz litigation. [read post]
21 Jul 2016, 1:22 am
Arnold J considered the criteria set down by the Court of Appeal in Novartis v Hospira [2013], but noted that it was of concern that Lord Hoffman’s judgment in the Privy Council case National Commercial Bank Jamaica v Olint [2009] had not been cited. [read post]
